201 - 225 of 6,649
Number of results to display per page
TitleCreatorRelation Is Part Of
201 Visual Function and Retinal Structure Differences Between Relapsing Remitting and Secondary Progressive Multiple SclerosisLakshmi Leishangthem, Fareshta Khushzad, Jennifer Yarp, Vedha Mahesh, Lucas Kipp, May Han, Heather MossNANOS Annual Meeting 2020: Poster Session II: Scientific Advancements
202 Visual function and retinal nerve fiber layer thickness in Neuromyelitis optica: a longitudinal and comparative studyHage, Rabih; Cabre, Philippe; Jeannin, Severine; Merle, HaroldNANOS 2014: Poster Presentations
203 Visual Function and Freedom from Disease Activity in a Phase 3 Trial for Relapsing Multiple SclerosisBalcer, Laura J; Galetta, Steven L; Zhang, Annie; Arnold, RyanNANOS 2013: Poster Presentations
204 Visual Function and Disease Phenotype in Multiple SclerosisWu, Gregory F; Nano-Schiavi, ML; Galetta, Steven L; Cohen, Jeffrey A; Balcer, Laura JNANOS 2004: Scientific Platform Presentations (Session 2)
205 Visual Function After Mimimally Invasive Pituitary Surgery (MIPS)Kuruvilla, Ruben; Ewend, Matthew; Senior, Brent; Givre, SyndeeNANOS 2007: Poster Presentations
206 Visual Function after Cerebral HemispherectomyShauna Berry, Monica Chen, Federico Velez, Gary Mathern, Stacy PinelesNANOS 2018: Poster Presentations
207 Visual Fixation: Spasm, Paralysis, Nystagmus, and the Visual Grasp ReflexJames A. Sharpe, MD, FRCP(C) (1941-2013)NANOS 1985: Ocular Oscillations Symposium
208 Visual Findings in Patients Undergoing Endoscopic Resection of Mid Skull Base LesionsNewman, Steven A; Jane, John ANANOS 2006: Poster Presentations
209 The Visual Fields: Techniques and AnalysisJoel S. Glaser, MD (1938 - 2011)NANOS 1978: Various Subjects Symposium (Session 2)
210 Visual fields with interpretation only - a preliminary evaluationLossen, Victoria I; Leavitt, Jacqueline ANANOS 2014: Poster Presentations
211 Visual Fields in the Ischemic Optic Neuropathy Treatment Trial at Baseline and Follow-upSteven E. Feldon; Lori Levin; Roberta W. Scherer; Anthony C. Arnold; Sophia M. Chung; Lenworth N. Johnson; Gregory S. Kosmorsky; Steven A. Newman; Joanne S. Katz; Patricia W. Langenberg; P. David Wilson; Shalom E. Kelman; Kay Dickersin
212 Visual Fields in Temporal Lobe ResectionWayne T. Cornblath, MD, Clinical Professor, Ophthalmology and Visual Sciences, Professor, Department of Neurology, University of MichiganNANOS 1992: Poster Presentations (Session 1)
213 Visual Fields in Patients with Posterior GPi Pallidotomy for Parkinson's DiseaseBiousse, Valerie; Newman, N J; Vitek, J L; Bakay, R A E; Delong, M R
214 The Visual FieldsJoel S. Glaser, MD (1938 - 2011)NANOS 1980: Various Subjects Symposium (Session 2)
215 The Visual FieldsJoel S. Glaser, MD (1938 - 2011)NANOS 1980: Optic Chiasm Symposium
216 Visual Field Variation in Patients with Central Retinal Vein Occlusion Treated with Optic Nerve Sheath DecompressionMcHenry, John G; Spoor, Thomas C; Ramachandran, Ethiraj; Skidmore, Ernest CNANOS 1995: Poster Presentations (Session II)
217 Visual Field Variability in Patients with Pseudotumor Cerebri Treated with Optic Nerve Sheath DecompressionMcHenry, John G; Spoor, Thomas C; Kardasis, Christopher T; Nemeth, Gabor GNANOS 1995: Poster Presentations (Session II)
218 Visual Field Technician Performance in the Ocular Hypertensive Treatement Study (OHTS)Keltner, John L; Johnson, CA; Cello, KE; Kass, MA; Gordon, MO; Bandermann, SE; Edwards, MANANOS 2001: Poster Presentations
219 Visual Field Screening: Perspective, Masked Trial With a Commercial Laser PointerVolpe, NJ; Galetta, SL; Liu, GT; Maguire, MG; Balcer, LJNANOS 2001: Poster Presentations
220 Visual Field Rotation as Presumptive Evidence of Ocular CyclodeviationEgan, Robert A; Morrow, Mark JNANOS 2014: Poster Presentations
221 Visual Field Restoration Therapy: Point-CounterpointNewman, Nancy J; Miller, Neil RNANOS 2006: Visual Field Restoration Therapy Symposium
222 Visual Field Reading Center Operations as Part of the Optic Neuritis Treatment TrialJohn L. Keltner, MD, UC Davis HealthNANOS 1992: Poster Presentations (Session 2)
223 Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS) and Optic Neuritis Treatment Trial (ONTT)Keltner,John L; Johnson, Chris A; Cello, Kimberly; Fan, Juanjuan; Levine, Richard A; Bandermann, Shannan E; Kass, Michael A; Gordon, Mae O; Beck, Roy WNANOS 2006: Poster Presentations
224 Visual Field Profile of Optic Neuritis: A Final Follow-Up Report from the Optic Neuritis Treatment Trial (ONTT) from Baseline to 15 YearsJohn L. Keltner, MD, UC Davis Health; Chris A. Johnson, MD, Devers Eye Institute; Cello, Kimberly; Gal, Robin; Beck, RoyNANOS 2010: Scientific Platform Presentations
225 Visual Field Profile of Optic Neuritis: A Final Follow-Up Report from the Optic Neuritis Treatment Trial (ONTT) from Baseline to 15 YearsJohn L. Keltner, MD, UC Davis Health; Chris A. Johnson, MD, Devers Eye Institute; Cello, Kimberly; Gal, Robin; Beck, RoyNANOS 2010: Scientific Platform Presentations
201 - 225 of 6,649